ULTA vs. AMPH
ULTA (Ulta Beauty, Inc.) and AMPH (Amphastar Pharmaceuticals, Inc.) are both stocks. ULTA operates in Specialty Retail (Consumer Cyclical), while AMPH operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, ULTA returned 7.00%/yr vs 2.48%/yr for AMPH. At a 0.19 correlation, their price movements are largely independent.
Performance
ULTA vs. AMPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ULTA achieves a -22.69% return, which is significantly higher than AMPH's -24.98% return. Over the past 10 years, ULTA has outperformed AMPH with an annualized return of 7.00%, while AMPH has yielded a comparatively lower 2.48% annualized return.
ULTA
- 1D
- -1.82%
- 1M
- -6.13%
- YTD
- -22.69%
- 6M
- -22.25%
- 1Y
- 1.87%
- 3Y*
- 1.77%
- 5Y*
- 6.68%
- 10Y*
- 7.00%
AMPH
- 1D
- -2.14%
- 1M
- 16.13%
- YTD
- -24.98%
- 6M
- -20.50%
- 1Y
- -22.19%
- 3Y*
- -24.72%
- 5Y*
- 0.17%
- 10Y*
- 2.48%
ULTA vs. AMPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ULTA Ulta Beauty, Inc. | -22.69% | 39.11% | -11.24% | 4.46% | 13.76% | 43.59% | 13.44% | 3.39% | 9.47% | -12.27% |
AMPH Amphastar Pharmaceuticals, Inc. | -24.98% | -27.88% | -39.97% | 120.74% | 20.31% | 15.81% | 4.25% | -3.07% | 3.43% | 4.45% |
Correlation
The correlation between ULTA and AMPH is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2014 | 0.19 |
Fundamentals
ULTA:
$20.56B
AMPH:
$933.34M
ULTA:
$26.57
AMPH:
$1.67
ULTA:
17.60
AMPH:
12.01
ULTA:
1.75
AMPH:
0.64
ULTA:
1.65
AMPH:
1.32
ULTA:
7.97
AMPH:
1.21
ULTA:
$12.71B
AMPH:
$720.53M
ULTA:
$5.00B
AMPH:
$341.13M
ULTA:
$1.81B
AMPH:
$155.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ULTA vs. AMPH — Risk / Return Rank
ULTA
AMPH
ULTA vs. AMPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ulta Beauty, Inc. (ULTA) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ULTA | AMPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.48 | ||
| Sortino ratioReturn per unit of downside risk | +0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 0.95 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.03 | -0.53 | +0.57 |
| Martin ratioReturn relative to average drawdown | 0.08 | -1.07 | +1.15 |
Loading charts...
Drawdowns
ULTA vs. AMPH - Drawdown Comparison
The maximum ULTA drawdown since its inception was -87.89%, which is greater than AMPH's maximum drawdown of -74.05%. Use the drawdown chart below to compare losses from any high point for ULTA and AMPH.
Loading charts...
Drawdown Indicators
| ULTA | AMPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.89% | -74.05% | -13.84% |
Max Drawdown (1Y)Largest decline over 1 year | -34.56% | -45.25% | +10.69% |
Max Drawdown (3Y)Largest decline over 3 years | -44.56% | -74.05% | +29.49% |
Max Drawdown (5Y)Largest decline over 5 years | -44.56% | -74.05% | +29.49% |
Max Drawdown (10Y)Largest decline over 10 years | -64.92% | -74.05% | +9.13% |
Current DrawdownCurrent decline from peak | -33.82% | -69.09% | +35.27% |
Average DrawdownAverage peak-to-trough decline | -20.81% | -24.08% | +3.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.13% | 22.54% | -8.41% |
Volatility
ULTA vs. AMPH - Volatility Comparison
The current volatility for Ulta Beauty, Inc. (ULTA) is 9.69%, while Amphastar Pharmaceuticals, Inc. (AMPH) has a volatility of 12.20%. This indicates that ULTA experiences smaller price fluctuations and is considered to be less risky than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ULTA | AMPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.69% | 12.20% | -2.51% |
Volatility (6M)Calculated over the trailing 6-month period | 25.04% | 46.17% | -21.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.39% | 53.78% | -20.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.26% | 45.07% | -10.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.32% | 42.71% | -4.39% |
Dividends
ULTA vs. AMPH - Dividend Comparison
Neither ULTA nor AMPH has paid dividends to shareholders.
Financials
ULTA vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Ulta Beauty, Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ULTA vs. AMPH - Profitability Comparison
ULTA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ulta Beauty, Inc. reported a gross profit of 1.27B and revenue of 3.16B. Therefore, the gross margin over that period was 40.1%.
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.
ULTA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ulta Beauty, Inc. reported an operating income of 448.26M and revenue of 3.16B, resulting in an operating margin of 14.2%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.
ULTA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ulta Beauty, Inc. reported a net income of 340.47M and revenue of 3.16B, resulting in a net margin of 10.8%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.
Frequently Asked Questions
ULTA and AMPH have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMPH has higher volatility (12.20%) compared to ULTA (9.69%). In terms of maximum drawdown, ULTA dropped -87.89% vs AMPH's -74.05%.
ULTA currently has the higher Sharpe Ratio (0.03 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ULTA and AMPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer